Paper925886
Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.
Wagner JG and 1 other. J Pharmacokinet Biopharm, 1977. Cited by 51 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin. Papers, record 925886. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/925886
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Availability | Major topic |
| Biopharmaceutics | Major topic |
| Digoxin | Major topic |
| Humans | |
| Mathematics |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,122,564 | Correlation of digoxin-tablet dissolution-rate with biological availability. | Lancet | 1973 | https://conductscience.org/library/papers/4122564 | PubMed |
| 2 | 1,159,622 | Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses. | J Pharmacokinet Biopharm | 1975 | https://conductscience.org/library/papers/1159622 | PubMed |
| 3 | 4,827,467 | Intravenous digoxin as a bioavailability standard: slow infusion and rapid injection. | Clin Pharmacol Ther | 1974 | https://conductscience.org/library/papers/4827467 | PubMed |
| 4 | 4,850,764 | Bioavailability and dissolution properties of two commercial digoxin tablets. | J Pharm Sci | 1974 | https://conductscience.org/library/papers/4850764 | PubMed |
| 5 | 1,269,214 | A completely absorbed oral preparation of digoxin. | Clin Pharmacol Ther | 1976 | https://conductscience.org/library/papers/1269214 | PubMed |
| 6 | 1,122,665 | Letter: Intravenous digoxin as a bioavailability standard. | Clin Pharmacol Ther | 1975 | https://conductscience.org/library/papers/1122665 | PubMed |
| 7 | 4,752,307 | Pharmacokinetics of digoxin: interpreting bioavailability. | Br Med J | 1973 | https://conductscience.org/library/papers/4752307 | PubMed |
| 8 | 797,491 | Bioavailability of drugs: the digoxin dilemma. | Clin Pharmacokinet | 1976 | https://conductscience.org/library/papers/797491 | PubMed |
| 9 | 959,319 | Assessment of methodology in single-dose studies of digoxin bioavailability. | Pharmacology | 1976 | https://conductscience.org/library/papers/959319 | PubMed |
| 10 | 4,644,642 | An overview of the analysis and interpretation of bioavailability studies in man. | Pharmacology | 1972 | https://conductscience.org/library/papers/4644642 | PubMed |
| 11 | 4,412,196 | Bioavailability of digoxin tablets and elixir in the fasting and postprandial states. | Clin Pharmacol Ther | 1974 | https://conductscience.org/library/papers/4412196 | PubMed |
| 12 | 957,127 | Biased bioavailability estimates. | J Pharm Sci | 1976 | https://conductscience.org/library/papers/957127 | PubMed |
| 13 | 859,101 | Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses. | J Pharmacokinet Biopharm | 1977 | https://conductscience.org/library/papers/859101 | PubMed |
| 14 | 4,426,150 | Comparison of one- and six-day urinary digoxin excretion in single-dose bioavailability studies. | Clin Pharmacol Ther | 1974 | https://conductscience.org/library/papers/4426150 | PubMed |
| 15 | 4,741,375 | Curve fitting by spline and Akima methods: possibility of interpolation error and its suppression. | Phys Med Biol | 1973 | https://conductscience.org/library/papers/4741375 | PubMed |
| 16 | 4,758,424 | Biological availability of digoxin from Lanoxin produced in the United Kingdom. | Br Med J | 1973 | https://conductscience.org/library/papers/4758424 | PubMed |
| 17 | 4,479,121 | Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets. | JAMA | 1974 | https://conductscience.org/library/papers/4479121 | PubMed |
| 18 | 10,123 | Effect of sulfasalazine on digoxin bioavailability. | Clin Pharmacol Ther | 1976 | https://conductscience.org/library/papers/10123 | PubMed |
| 19 | 4,678,961 | Absorption of orally given digoxin preparations. | JAMA | 1972 | https://conductscience.org/library/papers/4678961 | PubMed |
| 20 | 4,739,492 | Equivalence lack in digoxin plasma levels. | JAMA | 1973 | https://conductscience.org/library/papers/4739492 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 21,446,834 | Organophosphorus pesticide degradation product in vitro metabolic stability and time-course uptake and elimination in rats following oral and intravenous dosing. | Xenobiotica | 2011 | https://conductscience.org/library/papers/21446834 | PubMed |
| 20,218,011 | Comparison of the in vitro and in vivo release of digoxin from four different soft gelatin capsule formulations. | J Pharmacokinet Biopharm | 1979 | https://conductscience.org/library/papers/20218011 | PubMed |
| 19,430,911 | Prediction of modified release pharmacokinetics and pharmacodynamics from in vitro, immediate release, and intravenous data. | AAPS J | 2009 | https://conductscience.org/library/papers/19430911 | PubMed |
| 7,306,427 | Absorption and bioavailability of oral erythromycin. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/7306427 | PubMed |
| 7,277,206 | Evidence of nonlinearity in digoxin pharmacokinetics. | J Pharmacokinet Biopharm | 1981 | https://conductscience.org/library/papers/7277206 | PubMed |
| 7,014,827 | A standard approach to compiling clinical pharmacokinetic data. | J Pharmacokinet Biopharm | 1981 | https://conductscience.org/library/papers/7014827 | PubMed |
| 6,668,552 | Sampling strategies for noncompartmental estimation of mean residence time. | J Pharmacokinet Biopharm | 1983 | https://conductscience.org/library/papers/6668552 | PubMed |
| 3,830,717 | Steroid metabolism in isolated rat hepatocytes. | Eur J Drug Metab Pharmacokinet | 1985 | https://conductscience.org/library/papers/3830717 | PubMed |
| 2,614,683 | Optimal design allocations for estimating area under curves for studies employing destructive sampling. | J Pharmacokinet Biopharm | 1989 | https://conductscience.org/library/papers/2614683 | PubMed |
| 671,227 | Time to reach steady state and prediction of steady-state concentrations for drugs obeying Michaelis-Menten elimination kinetics. | J Pharmacokinet Biopharm | 1978 | https://conductscience.org/library/papers/671227 | PubMed |
| 41,924 | A method to predict infinity values for biexponential processes. | J Pharmacokinet Biopharm | 1979 | https://conductscience.org/library/papers/41924 | PubMed |
| 39,764 | Methods for evaluation of urinary excretion parameters of alclofenac after I.M. administration of its water soluble lysine salt in man. | Eur J Drug Metab Pharmacokinet | 1979 | https://conductscience.org/library/papers/39764 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/925886
GET https://conductscience.org/api/papers/v1/925886/references?page=2